Bae, Minwoo; Dong, Xueyang; Avila-Pacheco, Julian; Inyama, Fechi; Hill-Maini, Vayu; Clish, Clary; Balskus, Emily P

DOI:

Abstract

is an anti-aging and anti-inflammatory gut bacterial metabolite derived from (EA), a polyphenol abundant in berries and nuts. The conversion of EA to involves multiple chemically challenging phenol dehydroxylation steps that produce urolithins with varying bioactivities. Despite their biological and chemical significance, the bacterial enzymes responsible for urolithin production remain unidentified. Here, we use differential gene expression analysis, anaerobic protein expression, and enzyme assays to identify members of two distinct molybdenum enzyme families (the DMSO reductase family and the family) capable of regioselective dehydroxylation and urolithin generation. These two enzyme families have distinct substrate requirements, suggesting they employ different catalytic mechanisms for phenol dehydroxylation. Multi-omics analysis of a human cohort uncovers decreased levels of and genes encoding urolithin A-producing enzymes in patients with inflammatory bowel disease (IBD), implying reduced health effects of EA consumption in this setting. Together, this study elucidates the molecular basis of urolithin production, expands the known enzymatic repertoire of the human gut microbiome, and suggests a potential link between gut bacterial urolithin production and host inflammation.

Keywords

Molybdenum enzyme ; Gut microbiome ; Diet ; Polyphenol ; Urolithin

Purchased from AmBeed